Rethinking acute kidney injury in adults with type 2 diabetes: the role of early enteral nutrition
Published
September 3, 2024
Paper ID
PAP-000236
Status
Published
DOI
10.65712/tmj.test000494
Advance Services
Abstract
Background: acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes. Methods: Missing data were handled with multiple imputation. Results: Effects were consistent across prespecified subgroups. acute kidney injury occurred in 15% of the intervention group versus 14% of controls. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Guidelines make only a weak recommendation on early enteral nutrition. Earlier studies of early enteral nutrition were small or single-centre. acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes.
The cost of acute kidney injury to health systems is substantial. Guidelines make only a weak recommendation on early enteral nutrition. acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes.
Guidelines make only a weak recommendation on early enteral nutrition. acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes.
Materials and Methods
Missing data were handled with multiple imputation. Eligible participants were adults with type 2 diabetes. We conducted a multicentre observational study across 4 centres between 2019 and 2021.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was acute kidney injury, assessed blind to allocation.
Missing data were handled with multiple imputation. Eligible participants were adults with type 2 diabetes.
Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation.
Results
2141 participants were included (median age 61 years). The adjusted odds ratio was 0.82 (95% CI 0.24 to 0.79). acute kidney injury occurred in 6% of the intervention group versus 26% of controls.
4077 participants were included (median age 41 years). The adjusted odds ratio was 0.72 (95% CI 0.27 to 0.66). Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Male | 435 | 120 | 3.1 | 0.48 | 0.21–1.6 |
| Centre A | 614 | 94 | 38.4 | 0.78 | 0.54–1.21 |
| Age ≥ 65 | 774 | 43 | 37.6 | 0.79 | 0.32–1.39 |
| Age ≥ 65 | 509 | 51 | 38.4 | 0.44 | 0.22–1.20 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
4610 participants were included (median age 35 years). Serious adverse events were rare and similar between groups.
Discussion
Future work should test early enteral nutrition in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Future work should test early enteral nutrition in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Future work should test early enteral nutrition in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. These findings suggest that early enteral nutrition is associated with better acute kidney injury in adults with type 2 diabetes. Residual confounding cannot be excluded.
Conclusions
Early enteral nutrition may be offered for adults with type 2 diabetes to improve acute kidney injury.
References
1. Farouk J, Osei U, et al. Point-of-care ultrasound and health-related quality of life. N Engl J Med. 2013;222(10):414-1012.
2. Lindqvist C, Kowalski I, et al. Low-dose aspirin and falls. BMC Med. 2022;218(12):620-1774.
3. Tanaka M, Osei U, et al. Continuous glucose monitoring and 30-day readmission. Diabetes Care. 2021;54(3):719-1156.
4. Kaur Z, Schmidt H, et al. Prone positioning and time to diagnosis. Diabetes Care. 2009;176(6):151-1012.
5. Nakamura T, Rossi D, et al. SGLT2 inhibitors and surgical site infection. Pediatrics. 2018;128(10):377-1272.
6. Novak P, Herrera J, et al. An enhanced recovery pathway and health-related quality of life. Ann Intern Med. 2020;24(9):581-1337.
7. Nakamura N, Herrera O, et al. Early enteral nutrition and 30-day readmission. N Engl J Med. 2014;59(11):7-1798.
8. Zhang W, Silva L, et al. Early enteral nutrition and length of stay. Ann Intern Med. 2009;110(8):248-1785.
Appendices
Ethics approval: IRB-4497.